ERG has a role in various leukemia [116,117] and in Ewing sarcoma [118], and more recently it has been found as being overexpressed in some prostate cancer patients due to a genomic fusion with the androgen dependent promoter of the TMPRSS2 gene [119]. Here, ERG is linked to prostate carcinoma.